Get started
Author

Sara Chekalil

ORCID: 0000-0003-2995-410X
Observed ORCID: 0000-0003-2995-410X
OpenAlex ID: A5004405755
Pilot Trial of Arginine Deprivation Plus Nivolumab and Ipilimumab in Patients with Metastatic Uveal Melanoma
2022 · Lukas Kraehenbuehl, Aliya Holland, et al. · Cancers · 21
PDF
Abstract 646: Characteristics of skin microbiome in immune related cutaneous adverse events
2023 · Lukas Kraehenbuehl, John Frame, et al. · Cancer Research · 2
Antimicrobial Exposure and Immune-Related Cutaneous Adverse Events During Immune Checkpoint Blockade Therapy
2025 · Lukas Kraehenbuehl, Stephanie Gu, et al. · JAMA Dermatology · 1
476 The skin microbiome in immune-related cutaneous adverse events (ircAE) differs from that of patients without ircAE
2024 · Lukas Kraehenbuehl, Frame John, et al. · Journal for ImmunoTherapy of Cancer
475 Exposure to antibiotic interventions as a potential risk factor for developing immune-related cutaneous adverse events in patients treated with immune checkpoint blockade for cancer
2024 · Lukas Kraehenbuehl, Stephanie Gu, et al. · Journal for ImmunoTherapy of Cancer
Works count: 5
Citation count: 24
H-index: 2
I10-index: 1
Year
Topic
Type